Colon
Study Name: (Azur2)
- Cancer Stage: III
- Key Inclusion: dMMR/MSI-H Resectable Colon Cancer
- Description: Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
- Study Number: Azur-2
- NCT#: NCT05855200
-
Frederick, MD 21702
301-694-5861 More Information -
Frederick, MD 21702
301-663-4774 More Information -
Frederick, MD 21702
240-215-6310 More Information -
Frederick, MD 21702
301-694-5580 More Information -
Frederick, MD 21702
240-566-4100 More Information -
Frederick, MD 21702
240-566-4100 More Information -
Frederick, MD 21702
240-566-4500 More Information
/
View All